These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8704248

  • 1. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.
    Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE.
    Blood; 1996 Aug 01; 88(3):907-14. PubMed ID: 8704248
    [Abstract] [Full Text] [Related]

  • 2. Conjugation and evaluation of 7E3 x P4B6, a chemically cross-linked bispecific F(ab')2 antibody which inhibits platelet aggregation and localizes tissue plasminogen activator to the platelet surface.
    Neblock DS, Chang CH, Mascelli MA, Fleek M, Stumpo L, Cullen MM, Daddona PE.
    Bioconjug Chem; 1992 Aug 01; 3(2):126-31. PubMed ID: 1515466
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
    Gold HK, Gimple LW, Yasuda T, Leinbach RC, Werner W, Holt R, Jordan R, Berger H, Collen D, Coller BS.
    J Clin Invest; 1990 Aug 01; 86(2):651-9. PubMed ID: 2384607
    [Abstract] [Full Text] [Related]

  • 4. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
    Hato T, Watanabe A, Nakatani S, Minamoto Y, Fujita S.
    Thromb Haemost; 1995 Jan 01; 73(1):138-43. PubMed ID: 7537917
    [Abstract] [Full Text] [Related]

  • 5. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
    Coller BS.
    J Clin Invest; 1985 Jul 01; 76(1):101-8. PubMed ID: 2991335
    [Abstract] [Full Text] [Related]

  • 6. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties.
    Suzuki K, Sato K, Kamohara M, Kaku S, Kawasaki T, Yano S, Iizumi Y.
    Biol Pharm Bull; 2002 Aug 01; 25(8):1006-12. PubMed ID: 12186399
    [Abstract] [Full Text] [Related]

  • 7. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rüdiger S, Taubitz W, Fischer J, Müller I, Meier D, Patscheke H, Schömig A.
    Thromb Haemost; 2000 Jun 01; 83(6):915-22. PubMed ID: 10896249
    [Abstract] [Full Text] [Related]

  • 8. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.
    Simon DI, Xu H, Ortlepp S, Rogers C, Rao NK.
    Arterioscler Thromb Vasc Biol; 1997 Mar 01; 17(3):528-35. PubMed ID: 9102172
    [Abstract] [Full Text] [Related]

  • 9. Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic idiopathic thrombocytopenic purpura.
    Hou M, Stockelberg D, Kutti J, Wadenvik H.
    Br J Haematol; 1995 Dec 01; 91(4):944-50. PubMed ID: 8547147
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibody [7E3 F(ab')2] prevents arterial but not venous rethrombosis.
    Sudo Y, Kilgore KS, Lucchesi BR.
    J Cardiovasc Pharmacol; 1995 Aug 01; 26(2):241-50. PubMed ID: 7475049
    [Abstract] [Full Text] [Related]

  • 11. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
    Liu CZ, Hur BT, Huang TF.
    Thromb Haemost; 1996 Oct 01; 76(4):585-91. PubMed ID: 8903000
    [Abstract] [Full Text] [Related]

  • 12. Blockade of the human platelet GPIIb/IIIa receptor by a murine monoclonal antibody Fab fragment (7E3): potent dose-dependent inhibition of platelet function.
    Bhattacharya S, Jordan R, Machin S, Senior R, Mackie I, Smith CR, Schaible TF, Weisman HF, Lahiri A.
    Cardiovasc Drugs Ther; 1995 Oct 01; 9(5):665-75. PubMed ID: 8573549
    [Abstract] [Full Text] [Related]

  • 13. Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists.
    Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald D.
    Circulation; 1999 May 04; 99(17):2231-8. PubMed ID: 10226086
    [Abstract] [Full Text] [Related]

  • 14. 7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis.
    Sassoli PM, Emmell EL, Tam SH, Trikha M, Zhou Z, Jordan RE, Nakada MT.
    Thromb Haemost; 2001 May 04; 85(5):896-902. PubMed ID: 11372685
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.
    Mickelson JK, Simpson PJ, Lucchesi BR.
    J Mol Cell Cardiol; 1989 Apr 04; 21(4):393-405. PubMed ID: 2746660
    [Abstract] [Full Text] [Related]

  • 16. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG, Vyzova TV, Lukin VV, Tikhomirov OIu, Berndt M, Kouns W, Mazurov AV.
    Biokhimiia; 1996 Mar 04; 61(3):412-28. PubMed ID: 8724599
    [Abstract] [Full Text] [Related]

  • 17. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
    Trikha M, Zhou Z, Timar J, Raso E, Kennel M, Emmell E, Nakada MT.
    Cancer Res; 2002 May 15; 62(10):2824-33. PubMed ID: 12019160
    [Abstract] [Full Text] [Related]

  • 18. Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa.
    Christopoulos C.
    Clin Exp Immunol; 1994 Oct 15; 98(1):6-11. PubMed ID: 7923885
    [Abstract] [Full Text] [Related]

  • 19. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS, Peerschke EI, Seligsohn U, Scudder LE, Nurden AT, Rosa JP.
    J Lab Clin Med; 1986 Apr 15; 107(4):384-92. PubMed ID: 2420911
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura.
    Hansen RJ, Balthasar JP.
    J Pharmacol Exp Ther; 2001 Jul 15; 298(1):165-71. PubMed ID: 11408538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.